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ABSTRACT  
OBJECTIVE:  To evaluate the effectiveness of a telephone-delivered behavioral weight loss 
and physical activity intervention targeting Australian primary care patients with type 2 
diabetes. 
RESEARCH DESIGN AND METHODS: Pragmatic randomized controlled trial of 
Telephone Counseling (n = 151) versus Usual Care (n = 151). Reported here are 18-month 
(end-of-intervention) and 24-month (maintenance) primary outcomes of weight, moderate- to 
vigorous-intensity physical activity (MVPA; via accelerometer) and HbA1c. Secondary 
outcomes include dietary energy intake and diet quality, waist circumference, lipids and 
blood pressure. Data were analyzed via adjusted linear mixed models with multiple 
imputation of missing data. 
RESULTS: Relative to Usual Care, Telephone Counseling participants achieved modest, but 
significant improvements in weight loss (-1.42, 95% CI: -2.54, -0.30% of baseline body 
weight), MVPA (RR = 1.42, 95% CI: 1.06, 1.90), diet quality (2.72, 95% CI: 0.55, 4.89) and 
waist circumference (-1.84, 95% CI: -3.16,-0.51 cm), but not in HbA1c (RR=0.99, 95% CI: 
0.96, 1.02) or other cardio-metabolic markers. None of the outcomes showed a significant 
change/deterioration over the maintenance period. However, only the intervention effect for 
MVPA remained statistically significant at 24 months. 
CONCLUSIONS: The modest improvements in key diabetes management outcomes 
observed following behaviorally-based telephone counseling for adults with type 2 diabetes 
need to be considered in terms of their potential for broad population reach.  
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The high prevalence of overweight and obesity is driving a type 2 diabetes epidemic 
worldwide (1). Diabetes prevalence in adults has increased over the last decade from 8.2% to 
11.3% in the USA (2) and from 8.5% to 12% in Australia (3), with type 2 diabetes accounting 
for over 90% of cases (2). Lifestyle interventions – both intensive programs (4; 5) as well as 
scalable community-based versions (6; 7) - have had considerable success in reducing 
diabetes incidence and risk factors in populations at high risk. 
For those already diagnosed with diabetes, the challenges of applying lifestyle 
intervention programs have received considerable recent attention. The Look AHEAD study, 
a seminal trial that evaluated a multi-year, highly-resourced, intensive lifestyle intervention 
compared to standard diabetes education, demonstrated significant improvements in weight 
loss, related behavioral changes, HbA1c and other cardio-metabolic markers (8). Despite this, 
the Look AHEAD intervention was not successful at inducing changes in the primary 
endpoint of cardiovascular events (9).  Nevertheless, from a clinical perspective, the 
improvements achieved for diabetes management should not be underrated, as they are 
associated with reduced risk of diabetes-related vascular complications, associated organ 
damage, loss of function, and reduced quality of life (10). As such, promotion of lifestyle 
changes, particularly regular participation in physical activity (11) and moderate weight loss, 
remain crucial aspects of diabetes management (10). 
The issue of how to translate intensive lifestyle interventions into protocols more 
feasible for widespread delivery via primary health care and community settings, with long-
term sustainable impacts, requires attention. Telephone-delivered interventions are 
increasingly being investigated as they have the potential for broad population reach, and for 
delivering the repeated contacts necessary to promote maintenance of behavior change and 
related clinical improvements (12-15). 
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Living Well with Diabetes (LWWD) was a pragmatic trial of a telephone-delivered 
behavioral weight loss intervention targeting Australian primary care patients with type 2 
diabetes. It was designed to test a more scalable and sustainable version of an intensive 
intervention protocol. The initial (six-month) outcomes of LWWD showed small intervention 
effects for weight loss and physical activity, but not HbA1C (16). The purpose of this paper is 
to report on outcomes achieved at the end of the extended 18-month intervention, as well as 
at the final 24-month maintenance follow-up. Primary outcomes were weight loss, moderate- 
to vigorous-intensity physical activity (MVPA), and HbA1c. Secondary outcomes were 
dietary energy intake and diet quality, waist circumference, fasting blood lipids and blood 
pressure. 
 
RESEARCH DESIGN AND METHODS 
LWWD was a two-arm randomized controlled trial, the protocol for which has been 
published (17). Participants were recruited from nine general (primary care) practices in the 
city of Logan (population 270,000), a large ethnically and socioeconomically diverse 
community in the state of Queensland (Australia), 35 kilometres from Brisbane (the state 
capital). Ethical approval was granted from The University of Queensland Behavioral and 
Social Sciences Ethical Review Committee. 
 
Patient recruitment and randomization 
Within practices, 1407 eligible patients (i.e., diagnosed type 2 diabetes; aged 20–75 years; 
with a listed telephone number) were identified using electronic medical records (Figure 1). 
Patients not initially excluded by General Practitioner (GP) screening for contraindications to 
unsupervised physical activity (n=908) were posted study materials by the GP and if not 
declining further contact (n=206), were followed up by study staff for eligibility and consent. 
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Eligible patients were inactive (self-reported <5 days/week of ≥30min planned exercise) 
and/or overweight or obese (body mass index [BMI] ≥25.0 kg/m2), not using weight loss 
medications and without previous or planned bariatric surgery. Of those reached via 
telephone and eligible (n=420), 302 (71.9%) agreed to participate, completed the baseline 
assessment and were randomized to the either Telephone Counseling or Usual Care groups. 
Randomization was by the minimization method (18) using the MINIM program 
(www.sghms.ac.uk/depts/phs/guide/randser.htm). The minimization method balanced 
treatment groups across the following prognostic factors (without weighting for importance): 
gender; age (≥ 55 years); BMI (≥ 40 kg/m2); HbA1c (≥ 8%); self-reported physical activity 
level (meeting Australian guidelines of ≥150 minutes and ≥5 days per week) (19); and, self-
reported diabetes management (i.e., insulin or combination therapy, traditional oral 
hypoglycemic medications, glucagon-like peptide-1 (GLP-1) agents, or lifestyle alone). GLP-
1 agents (e.g. GLP-1 mimetics such as Exenatide  and GLP-1 enhancers such as Sitagliptin) 
were considered separately as these medications may cause less weight gain than traditional 
diabetes medications (20). 
 
Usual Care  
Usual Care participants were mailed a brief summary of their assessment results following 
each assessment, as well as standard, diabetes self-management education brochures. 
 
Telephone-delivered weight loss intervention 
The intervention, delivered entirely over the telephone, used a combined approach of 
increasing physical activity, reducing energy intake, and behavioral therapy. Participants 
received a detailed workbook and up to 27 telephone calls over the 18 months (four initial 
weekly calls; fortnightly calls for five months; monthly calls for 12 months) to support 
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initiation and maintenance of weight loss. The intervention followed a motivational 
interviewing approach (21) grounded in Social Cognitive Theory constructs of self-efficacy, 
social support and outcome expectancies (22), and emphasized behavior change strategies. 
These included: identifying benefits of weight loss; setting goals for gradual changes to 
physical activity and dietary intake; self-monitoring progress; problem-solving; utilizing 
available supports; and, focusing on achievements with appropriate rewards (23).  
Intervention targets for weight loss, physical activity and dietary intake were consistent with 
management goals for type 2 diabetes (10), with the aim to reduce HbA1c to less than 7%.  
Participants were encouraged to achieve moderate weight loss of 5–10% of initial body 
weight, with a loss of 1–2 kg per month (10).  A target of at least 210 minutes per week (30 
minutes every day) of moderate-intensity, planned aerobic activity was recommended, 
consistent with the level of physical activity necessary to promote and maintain weight loss 
(24), along with resistance exercise (2–3 sessions/week) (25).  Individualised advice (26) was 
used to encourage participants to reduce daily energy intake by 2000 kJ (approximately 500 
kcal) by following healthy eating principles, including following a low-fat diet (i.e., total fat 
< 30% of energy and saturated fat < 7% of energy) with sufficient dietary fiber (25 grams/day 
for women and 30 grams/day for men).  Participants were provided with a pedometer and a 
set of digital scales.  Fidelity of intervention delivery was monitored via feedback to 
counselors following randomly recorded telephone calls and fortnightly clinical supervision 
meetings. Call attempts, completions and duration were tracked in the trial database. 
 
Primary and secondary outcomes, data collection and measures 
Primary outcomes were weight, accelerometer-derived moderate- to vigorous-intensity 
physical activity (MVPA) and HbA1C. Secondary outcomes were dietary energy intake and 
diet quality, waist circumference, fasting blood lipids and blood pressure. Data were collected 
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at baseline, six-, 18- (end of intervention), and 24-months (maintenance) via nurse home 
visits and telephone interviews by research staff blind to participants’ group allocation. 
Weight was measured in duplicate, without shoes or heavy clothing, using standard calibrated 
scales (Model TI TBF 350, Tanita Inc., Tokyo, Japan) to the nearest 0.1 kg. Height was 
measured in duplicate at baseline only using a portable stadiometer (Seca 214 height rod, 
Seca, Germany) to the nearest 0.1cm. Waist circumference was measured to the nearest 0.5 
cm at the superior border of the iliac crest. Blood pressure was measured in duplicate in the 
seated position by a portable sphygmomanometer (Gamma G5, Heine, Germany).  Blood 
samples were taken by registered nurses early in the morning after an overnight fast (at least 
10 hours), with participants instructed not to take any glucose-lowering medication prior to 
the assessment. Current diabetes medications were recorded. HbA1c was measured from 
whole blood samples by the high performance liquid chromatography method (Bio-Rad 
Variant II, Sydney, Australia). Total cholesterol, high density lipoprotein (HDL) cholesterol 
and triglycerides were measured by an enzymatic colorimetric assay with Roche Modular 
Chemistry Analyser (Tokyo, Japan). Low density lipoprotein (LDL) cholesterol was 
determined using the Friedewald equation (27). 
Nurses provided participants with a GT1M accelerometer (Actigraph, LLC, Fort 
Walton Beach, Florida) to collect physical activity data.  The hip-worn monitor was set to 
record in 60-second epochs. Participants were asked to wear the monitor for seven days 
during waking hours (except during water-based activities) and to record wear/removal times. 
Wear time was ascertained by research staff, who estimated wearing periods from times 
movement stopped or began coinciding with participant self-reported wear/removal periods. 
Using SAS 9.2 (SAS Institute Inc., Cary, NC), MVPA was identified as time spent at ≥1952 
counts per minute (cpm) during worn time on valid days (i.e., ≥10 hours of wear, no 
excessive counts ≥20,000 cpm). Weekly MVPA was estimated as seven times mean MVPA 
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on valid days, with a requirement of at least one valid day. Respectively at baseline, 6-, 18- 
and 24-months at least four valid days were provided by 98% (297/302), 97% (265/273), 
95% (234/246) and 96% (229/239) of participants and mean (±standard deviation) daily wear 
time for those with ≥ 1 valid wear day was 13.5±1.6 hours, 13.7±1.7, 13.6±1.8, and 13.7±1.8 
hours. 
Telephone interviews included a previously validated food frequency questionnaire 
assessing intake over the previous month (28). Coupled with the NUTTAB95 nutrient 
composition database (29), it was used to derive average daily energy and nutrient intake. 
Overall dietary quality was summarised in terms of the Diet Quality Index-Revised score 
(30), which ranges from 0 (worst) to 100 (best)  in terms of 10 dietary characteristics – total 
fat, saturated fat, dietary cholesterol, fruit, vegetables, grains, calcium, iron, dietary diversity 
and dietary moderation – relative to current Australian dietary recommendations (31).  
Demographic data and adverse events were also collected during the telephone interview. 
 
Statistical analysis 
Analyses were performed in SPSS version 21 (IBM Corporation, NY) and STATA version 
12 (StataCorp, TX). Statistical significance was set at p<0.05 (two-tailed). The sample size 
was chosen a priori to provide at least 90% power (with two-tailed significance of 5%) to 
detect minimum differences of interest (MDI) in primary outcomes of 5% weight loss (4.7 
kg), 0.6 HbA1c% and 60 minutes/week MVPA (17).  It was expected to provide adequate 
(≥80%) power to detect MDIs for diet (2 MJ energy intake and ½ a standard deviation diet 
quality [5.5]), waist circumference (5cm), HDL cholesterol and total/HDL cholesterol ratio 
(5%), and triglycerides (10%), but low power to detect MDIs for blood pressure (70% for 5 
mmHg systolic and 56% for 3mmHg diastolic), total cholesterol (57% for a 5% difference) 
and LDL cholesterol (12.1% for a 5% difference). 
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Intervention effects were examined via linear mixed models which corrected for 
baseline values and potential confounders, identified as those variables with a significant 
association with the outcome p<0.2 (listed in Supplemental Table S1). Changes within 
groups were also examined using mixed models. For outcomes that were log-transformed to 
improve normality (HbA1c, MVPA, cholesterol and triglycerides), model results were 
exponentiated and expressed as relative rates. Models did not display problems with 
heteroscedascicity, non-linearity or non-normality. 
To evaluate sensitivity of conclusions to missing data, multiple imputation and 
completers analyses were both performed. Multiple imputation was by chained equations in 
STATA 12, using all analytic variables, variables associated with dropout, and when 
required, auxiliary variables to aid prediction of missing covariates. Results presented are 
based on multiple imputation, unless indicated otherwise. The analyses were repeated with a 
lower (≥ 574 cpm) and higher (≥ 2743cpm) cutpoint for MVPA (32), to evaluate the 
sensitivity of conclusions to choice of cutpoint. 
 
RESULTS 
The sample characteristics (Table 1) largely resembled the Australian Diabetes population 
with very little evidence of participation bias (16).  The sample (56% men) had a mean (± 
Standard Deviation) age of 58 (± 8.6) years and BMI of 33.1 (±6.1) kg/m2, and a median 
diabetes duration of 5 years (25th, 75th percentile: 2, 10 years). Most participants were 
Caucasian (87.4%), obese (68.2%) or overweight (26.2%), and not meeting physical activity 
guidelines (69.5%). In the Telephone Counseling (n=151) and Usual Care groups (n=151), 
respectively, insulin use was low at baseline (15.2%, 13.2%) but increased by 24-months 
(23.5%, 23.9%), and the percentages not on diabetes medications dropped between baseline 
(19.9%, 17.2%) and 24-months (18.2%, 12.8%). 
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Withdrawal rates were low and diminished over study duration (Figure 1). Loss to 
follow-up was not significantly different (p=0.278) between the Telephone Counseling 
(26.5%) and Usual Care (20.5%) groups. Dropouts had significantly higher HDL and greater 
use of insulin at baseline than completers (Supplemental Table S2). There was a non-
significant tendency for dropouts to be male, use oral hypoglycemic medication and have 
longer diabetes duration. Out of the 27 possible intervention calls, median (25th, 75th 
percentile) call receipt was 16 (9, 22) among Telephone group participants (n = 151), and 17 
(21, 23) in the 60.9% of Telephone participants who had not withdrawn from intervention or 
the study before end of intervention (n=92). Respectively, completion of ≥75% of scheduled 
calls was achieved by 36.4% (55/151) of Telephone group participants, or, 57.6% (53/92) of 
non-withdrawn Telephone participants. 
 
Intervention effects at end of intervention 
Intervention effects on primary and secondary outcomes are shown in Table 2. Interim (6-
month) outcomes (16) were not substantially different from end-of-intervention (18-month) 
outcomes and so are not discussed separately. At end-of-intervention (18-months) the 
Telephone Counseling group had modest, but significantly favorable outcomes relative to 
Usual Care for the primary outcomes of weight loss (-1.42 [95% CI: -2.54, -0.30]% of 
baseline body weight or -1.52 [-2.64, 0.39] kg) and MVPA, which was 42% higher in 
Telephone than Usual Care participants (RR = 1.42, 95% CI: 1.06, 1.90, or, 43.06 
minutes/week, 95% CI:15.04, 71.09 minutes/week), but not for HbA1c (RR=0.99, 95% CI: 
0.96, 1.02, i.e., -0.06%, 95% CI: -0.16, 0.20% or -0.7, 95% CI: -1.7, 2.2 mmol/mol).  In terms 
of secondary outcomes, modest but significant intervention effects were observed for diet 
quality (2.72, 95% CI: 0.55, 4.89) and waist circumference (-1.84 cm, 95% CI: -3.16,-0.51 
cm), but not for energy intake, cholesterol, triglycerides or blood pressure. Consideration of 
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the 95% confidence intervals ruled out as unlikely any meaningful intervention effects for 
HbA1c, energy intake and diastolic blood pressure. When changes within groups were 
examined, the telephone group exhibited modest improvements in most outcomes 
(Supplemental Table S3). Additionally, significant, meaningful within-group change was 
observed in both Telephone Counseling and Usual Care participants for some of the 
cholesterol outcomes (HDL, LDL, Total/HDL ratio). Notably, the intervention effects for 
MVPA related to a significant 25% decline in the usual care group (RR=0.8, 95% CI: 0.66, 
0.98) rather than improvement in the telephone group. Adverse events requiring 
hospitalisation were reported by 4 (3.4%) of Telephone Counseling and 4 (3.1%) of Usual 
Care participants, with events plausibly related to study participation (ie, musculoskeletal 
problems and digestive disturbance) reported by 17 (14.4%) and 28 (21.9%), respectively. No 
hypoglycemic events were reported. 
 
Maintenance 
MVPA was the only outcome in which there was a significant intervention effect after the 
six-month non-contact period (i.e., at 24-months), with mean MVPA being 44% higher in the 
Telephone Counseling group than the Usual Care group (RR = 1.44, 95% CI: 1.12, 1.85, or 
38.95, 95% CI: 12.55, 65.35 mins/week). Although not statistically significant, there was 
some attenuation in the intervention effect sizes for weight loss (-0.72% vs. -1.42%), diet 
quality (1.79 vs. 2.72 units) and waist circumference (-0.95 vs. -1.84 cm) (Table 3). 
 
Target/recommendation adherence 
At end-of-intervention, only a small percentage of Telephone Counseling and Usual Care 
groups respectively achieved program targets of  ≥ 5% weight loss (21.0%, 13.2%), ≥210 
mins/week MVPA (34.8%, 27.8%), ≥ 2MJ energy reduction (22.8%, 18.8%) (Supplemental 
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Figure SF1). However both Telephone and Usual Care groups, respectively, quite commonly 
met recommendations for HbA1c ≤ 7% (10) both at baseline (45.7%, 53.0%) and end-of-
intervention (43.9%, 42.4%)  (Supplemental Figure SF1).  Weight gain (≥ 1%) was common 
at 6-, 18- , and 24-months, more so within the Usual Care group (38.6%, 43.1%, 36.6%) than 
the Telephone group (29.5%, 31.5%, 18.7%) (Supplemental Figure SF1). 
 
Sensitivity analyses 
Completers analysis and the multiple imputation yielded almost identical results (Table 2). 
Conclusions were robust to the choice of MVPA cutpoint; significant intervention effects 
favoring the Telephone Counseling group were still observed even with a very low (≥ 574) 
and a very high cutpoint for MVPA (≥ 2743) (32) (data not shown). 
 
CONCLUSIONS 
The LWWD trial evaluated a broad reach, telephone-delivered intervention targeting 
sustained improvements in weight loss and physical activity in adults with type 2 diabetes 
recruited from primary care settings.  At the end of the 18-month intervention, statistically 
significant, but clinically modest benefits were observed for weight loss, MVPA and diet 
quality. Changes were maintained at the 24-month follow-up, though were only statistically 
significant for MVPA.  There were no statistically significant improvements in any of the 
cardio-metabolic biomarkers, including HbA1c (one of the primary outcomes). 
The LWWD trial sought to recruit a representative sample of Australian primary care 
patients with type 2 diabetes and deliver an intervention that made participation as easy as 
possible (i.e., without the need for clinic visits). While the sample was largely representative, 
engaging Telephone Counseling participants in the intervention proved challenging. Attrition 
at 24 months was non-differential and modest in both groups, yet approximately 40% of 
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Telephone participants chose to discontinue receiving the intervention either by withdrawal 
from the intervention or from study participation all together.  Further, even among 
Telephone group participants who did not withdraw, intervention delivery was difficult, with 
just over half completing at least 75% of scheduled intervention calls. This was despite 
documentation of multiple call attempts and mostly participant-related reasons for missed 
intervention calls. While the optimal dose of intervention cannot be examined given the study 
design, planned analysis of the associations between call completion and study outcomes and 
the characteristics of those completing fewer and more calls will further inform the issue of 
participant engagement. 
Despite challenges in intervention delivery, our findings for weight loss are not 
different to those seen in previous trials of lifestyle and behavioral weight loss interventions 
involving people with type 2 diabetes. In a meta-analysis of 22 such studies, Norris and 
colleagues reported pooled weight loss of 1.7kg (95% CI 0.3 to 3.2kg) or 3.1% of baseline 
body weight, compared to the LWWD intervention effect for weight loss of 1.52kg (95% CI -
2.64 to -0.39kg) or -1.42% (95% CI -2.54 to -0.30%) of baseline body weight (33). As 
anticipated, the magnitude of the weight loss observed in LWWD was less than that seen in 
the intensive Look AHEAD trial (8). Additional analyses, via categorisation of the weight 
changes, suggested that the changes observed in LWWD were related both to the weight loss 
in the Telephone group as well as prevention of weight gain, with 36.6% of Usual Care 
participants and only 18.7% of Telephone group participants experiencing weight gains ≥1% 
of body weight over two years. 
Our intervention effect for MVPA is similar to what has been previously reported in 
type 2 diabetes (34).  The modest but significant intervention effect of approximately 40 
minutes per week is consistent with the modest standardized weighted mean difference in 
objectively measured physical activity of 0.45 (95% CI 0.21, 0.68) reported in a recent meta-
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analysis (34). Further, as with weight loss, there was some suggestion of a prevention effect, 
with a considerable decline in MVPA observed in the Usual Care group at 24 months. 
Since the onset of this 5-year LWWD trial, a number of reports of studies of 
telephone-delivered interventions to improve glycemic control in type 2 diabetes have been 
published, and are summarized in a meta-analysis (15). Our findings for HbA1c were at the 
lower end of what might be expected based on Wu and colleagues’ review (15), which 
reported a standardized weighted mean difference of -0.44 (95% CI -0.93 to 0.06), i.e., an 
effect that is estimated as moderate but could plausibly be anywhere between no effect to a 
large beneficial effect. The review also showed that the interventions were not consistent in 
their impact on HbA1c (i.e., significant heterogeneity). Even three randomized controlled 
trials that were similar in recruitment and intervention protocols to LWWD, results were still 
mixed: no effect on glycemic control (also no meaningful weight loss) (35); significant 
improvement in glycemic control (despite no meaningful weight loss) (36); and, significant 
improvement in glycemic control (weight loss not reported) (37). 
Strengths of the LWWD trial include recruitment of a largely representative sample of 
Australian primary care patients with type 2 diabetes, objective assessment of primary 
clinical, anthropometric and behavioral outcomes (i.e., MVPA via accelerometer), inclusion 
of a maintenance assessment, and systematic tracking of implementation. Limitations include 
the collection of fairly crude data on diabetes medication usage and thus the inability to 
comprehensively control for medication usage and medication changes on primary outcomes, 
particularly HbA1c. 
In summary, reviews and individual studies of telephone-delivered diabetes 
management and lifestyle interventions, including LWWD, show fairly modest and in some 
cases null effects for glycemic control, weight loss and physical activity. As would be 
expected, these outcomes are considerably more modest than those observed in the intensive, 
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multi-year lifestyle Look AHEAD intervention. A similar attenuation of intervention effects 
has been reported in the adapted versions of the landmark USA and Finnish Diabetes 
Prevention Programs that have been scaled for delivery in resource-limited primary health 
care and community health contexts (6; 7). The question then becomes whether scarce 
resources should be devoted to intensive programs producing substantial improvements in 
clinical indicators and underlying behaviors for few, or to scalable programs producing small 
improvements, with the potential for broad population reach and impact on many, such as 
LWWD (38). 
In terms of lifestyle programs for adults living with type 2 diabetes, various 
jurisdictions in many developed countries now financially support the delivery of scaled 
diabetes prevention programs in community contexts. With some adaptations, such programs 
could also be made available to those living with type 2 diabetes. In Australia, a number of 
state health departments now offer a free, six-month telephone lifestyle and weight loss 
coaching service (the Get Healthy Information and Coaching Service or GHS) available to 
any adult in the state via clinician or self-referral. Moderate weight loss and behavioral 
improvements and maintenance following GHS completion have been reported (39; 40). 
While not specifically targeting diabetes prevention or management, those at risk for or living 
with diabetes are eligible, following clinician referral. 
These longer-term intervention and maintenance outcomes from the LWWD trial 
suggest that telephone counseling for adults with type 2 diabetes is effective in producing 
significant but modest weight loss and in maintaining physical activity improvements, but not 
in improving glycemic control. Telephone-delivered lifestyle coaching may be a vehicle 
through which to achieve wide population reach for those with and those living with, and at 
risk for, type 2 diabetes. Future research is needed to evaluate this, along with alternative, 
broad-reach intervention delivery modalities, such as mobile phone text messaging and smart 
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phone applications that may be able to address some of the challenges of participant 
engagement experienced in the LWWD trial.  
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